Site #0123 — Pittsburgh, Pennsylvania

Site #0123 is a clinical research site located in Pittsburgh, Pennsylvania, United States 15240.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site #0123 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma.

Sponsors: Bicara Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #0123?

Site #0123 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #0123 conducted?

Site #0123 has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma.

Is Site #0123 accredited by Crixeo Health?

Site #0123 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #0123?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.